Dantari Raises $47M in Round - San Fernando Valley Business Journal
Oncology company exits from stealth with funding.
Source: sfvbj.com
Page 12 - Pascal Touchon News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Pascal Touchon. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Pascal Touchon Today - Breaking & Trending Today
Atara Biotherapeutics, Inc. (NASDAQ:ATRA) Given Average Recommendation of "Hold" by Analysts
Atara Biotherapeutics, Inc. (NASDAQ:ATRA – Get Rating) has received a consensus recommendation of “Hold” from the eight analysts that are covering the firm, MarketBeat Ratings reports. Two research analysts have rated the stock with a sell recommendation, three have issued a hold recommendation and two have assigned a buy recommendation to the company. The average […]
Source: etfdailynews.com
Atara Biotherapeutics, Inc. (NASDAQ:ATRA) Q3 2022 Earnings Call Transcript
Operator: Good afternoon, everyone. Thank you for standing by, and welcome to the Atara Biotherapeutics Third Quarter 2022 Financial Results Conference Call.
Source: insidermonkey.com
Atara Biotherapeutics approval heralds off-the-shelf T-cell therapies
The EU approval of Atara Biotherapeutics' Ebvallo marks the first immunotherapy based on T cells sourced from healthy donors.
Source: labiotech.eu
Ebvallo™ given world's first approval of an allogeneic T-cell therapy
Ebvallo™ is the first authorised allogeneic T-cell immunotherapy and has been approved for EU patients with relapsed or refractory EBV+ PTLD.
Source: europeanpharmaceuticalreview.com